Autres langues Anupam Rasayan India Ltd

Actions

ANURAS

INE930P01018

Chimie de spécialité

Temps Différé NSE India S.E. 06:38:08 13/08/2026			Varia. 5j.	Varia. 1 janv.
1 209,90 ^INR	+0,46%		-0,15%	-8,17%

17/07	Anupam Rasayan India Ltd (NSEI:ANURAS) a acquis Mates Visa Consultancy Private Limited pour 0,01 million d'INR.	CI
15/07	Anupam Rasayan India Limited signe une lettre d'intention avec BASQUEVOLT, S.A. pour la fourniture potentielle à long terme d'un produit chimique de spécialité d'une valeur de 300 millions de dollars	CI

Autres langues

17/07	Anupam Rasayan India Ltd acquired Mates Visa Consultancy Private Limited for INR 0.01 million.
15/07	Anupam Rasayan India Limited Signs Letter Of Intent With BASQUEVOLT, S.A. For Potential Long-Term Supply Of Specialty Chemical Product Worth USD 300 Million
06/07	Tanfac Industries Limited announced that it expects to receive INR 1.734872962 billion in funding from Anupam Rasayan India Ltd, Alrox Enterprises Private Limited
11/06	Anupam Rasayan India Limited Commercialises ETFA Using Flow Chemistry
04/06	Crisil Places Anupam Rasayan Ratings on Watch Developing After Bliss GVS Acquisition Announcement
23/05	Anupam Rasayan India Ltd Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
23/05	Anupam Rasayan India Limited Announces Resignation of Vishal Thakkar as Deputy Chief Financial Officer and Key Managerial Personnel, Effective May 23, 2026
23/05	Anupam Rasayan India Ltd Recommends Final Dividend for the Financial Year 2025-26
23/05	Anupam Rasayan India Ltd proposed to acquire 26.21% stake in Bliss GVS Pharma Limited for INR 8.3 billion.
23/05	Anupam Rasayan India Ltd proposed to acquire 26.21% stake in Bliss GVS Pharma Limited for INR 8.3 billion.
23/05	Anupam Rasayan India Ltd entered into a share purchase agreement to acquire 43.30% stake in Bliss GVS Pharma Limited for INR 13.7 billion.
27/02	Anupam Rasayan India Ltd completed the acquisition of Jayhawk Fine Chemicals Corporation from CABB Group GmbH.
16/02	Anupam Rasayan India's Consolidated Profit Rises in Fiscal Q3
14/02	Anupam Rasayan India Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
13/02	Anupam Rasayan India denies plans to buy stake in Bliss GVS Pharma
10/12	Anupam Rasayan India to Buy Monitchem Kansas, Subsidiaries
09/12	Anupam Rasayan India approves acquisition of Monitchem Kansas
09/12	Anupam Rasayan India Ltd entered into a definitive agreement to acquire Evonik Jayhawk Fine Chemicals Corporation from CABB Group GmbH for $150 million.
17/10/25	Anupam Rasayan India Ltd Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
17/10/25	Anupam Rasayan India's Consolidated Net Profit Climbs in Fiscal Q2
13/08/25	Anupam Rasayan India Ltd Reports Earnings Results for the First Quarter Ended June 30, 2025
13/08/25	Anupam Rasayan India Ltd Reports Earnings Results for the First Quarter Ended June 30, 2025
15/07/25	Anupam Rasayan India Ltd Approves Interim Dividend for the Financial Year 2024-2025, Payable on or Before August 13, 2025
26/06/25	Anupam Rasayan India Limited Announces Resignation of Himanshu Bhatt as President-Projects, Effective Date Is June 26, 2025
12/06/25	Anupam Rasayan India Ltd Signs Master Purchase Agreement with Japanese Multinational Conglomerate, Expanding Strategic Reach in Japan